Ginkgo bioworks teams with quest diagnostics to provide covid-19 testing for k-12 schools nationwide

Boston, may 3, 2021 /prnewswire/ --  ginkgo bioworks ("ginkgo") today announced a collaboration with quest diagnostics (nyse:dgx) to provide covid-19 kindergarten through senior (k-12) school testing services to support classroom learning nationwide. the services are based on recommendations provided by the rockefeller foundation in its k-12 national testing action program : connecting schools with the nation's leading testing companies to safely reopen, which provides a testing roadmap for schools and cites both quest and ginkgo for their covid-19 testing expertise.
DGX Ratings Summary
DGX Quant Ranking